This week Finland, Sweden, and Denmark restricted the use of Moderna’s COVID-19 vaccine due to the risk of myocarditis in certain age groups, specifically for men under the age of 30. Nordic countries will offer the Pfizer BioNTech vaccine instead. However, reports of myocarditis have occurred following both Moderna and Pfizer’s mRNA vaccines.